Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Sex Transm Dis. 2021 Sep 1;48(9):615–619. doi: 10.1097/OLQ.0000000000001395

Figure 2. Concerns regarding various aspects of doxycycline PrEP/PEP among community members (n=205–212*).

Figure 2.

*Sample size varies for each question due to incomplete responses.

**Determined by assigning a numerical value to each level of response (i.e. “Not concerned at all”=1, “Very concerned”=5) and computing the average.